The University of Chicago Header Logo

Connection

Mitchell Posner to Capecitabine

Back to Details
This is a "connection" page, showing publications Mitchell Posner has written about Capecitabine.
Mitchell Posner
Connection Strength
0.088
Capecitabine
  1. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012 Feb; 19(2):384-91.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.